Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool
Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool. // Asian Journal of Urology. – URL: https://www.sciencedirect.com/science/article/pii/S2214388226001098?dgcid=rss_sd_all
Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool. Asian Journal of Urology. https://www.sciencedirect.com/science/article/pii/S2214388226001098?dgcid=rss_sd_all
“Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool.” Asian Journal of Urology.
@article{article36855,
title = {Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool},
journal = {Asian Journal of Urology},
url = {https://www.sciencedirect.com/science/article/pii/S2214388226001098?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...